Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133404) titled 'Clinical Significance of TP53 Mutations in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma' on Sept. 25.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
Condition:
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: case series:300;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=344200
Disclaimer: Curated by HT Syndication...